Apixaban | Factor Xa inhibitor
NMR (Conforms)
Available Options
| Size: | Price | Quantity | |
|---|---|---|---|
| 5 mg | $50.00 | ||
| 25mg | $185.00 |
Apixaban (503612-47-3) is a potent and selective inhibitor of both free and prothrombin-bound factor Xa, Ki = 0.8 nM.1 Clinically useful antithrombotic agent.2 Apixaban lowered risk of recurrent venous thromboembolism and major bleeding in high-risk patients.3
References/Citations:
- Turpie et al. (2007), Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases; Arterioscler. Vasc. Biol., 27 1238
- Lai et al. (2022), Effects of oral anticoagulant therapy in patients with pulmonary diseases; Front. Cardiovasc. Med., 9 987652
- Cohen et al. (2022), Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding; PLoS One, 17 e0274969
NMR (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Apixaban (503612-47-3) is a potent and selective inhibitor of both free and prothrombin-bound factor Xa, Ki = 0.8 nM.1 Clinically useful antithrombotic agent.2 Apixaban lowered risk of recurrent venous thromboembolism and major bleeding in high-risk patients.3
References/Citations:
- Turpie et al. (2007), Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases; Arterioscler. Vasc. Biol., 27 1238
- Lai et al. (2022), Effects of oral anticoagulant therapy in patients with pulmonary diseases; Front. Cardiovasc. Med., 9 987652
- Cohen et al. (2022), Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding; PLoS One, 17 e0274969
Related products
-
Rucaparib phosphate | PARP1 inhibitor
From $70.00CAS:459868-92-9Catalog Number:10-3321Activity:PARP1 inhibitorChemical Name:8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-oneAlternate Name:AG-14699; PF01367338Molecular Weight:421.36Molecular Formula:C19H18FN3O • H3PO4Solubility:Soluble in DMSO (up to 25 mg/ml).Physical Properties:Yellow solidPurity:98% by HPLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.Shipping Code:RT -
BI 2536 | Dual Plk/BRD4 inhibitor – Destabilizes Myc
From $75.00CAS:755038-02-9Catalog Number:10-4121Activity:Dual Plk/BRD4 inhibitor – Destabilizes MycChemical Name:4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamideMolecular Weight:521.67Molecular Formula:C28H39N7O3Solubility:Soluble in DMSO (up to 20 mg/ml) or in Ethanol (up to 25 mg/ml)Physical Properties:Off-white solidPurity:97% by HPLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.Shipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
